Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]

被引：0
|
作者：
Martha L. Campbell-Thompson
Desmond A. Schatz
John S. Kaddis
Mark A. Atkinson
机构：
[1] University of Florida,Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine
[2] University of Florida,Department of Pediatrics, College of Medicine
[3] City of Hope,Department of Information Sciences
来源：
Diabetologia | 2016年 / 59卷
关键词：
Chronic pancreatitis; Ductal hyperplasia; GAD autoantibodies; Heterogeneity; Insulitis; LADA; nPOD; PanIN; Relative pancreas weight; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：870 / 872
页数：2
相关论文
共 12 条
  • [1] Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]
    Campbell-Thompson, Martha L.
    Schatz, Desmond A.
    Kaddis, John S.
    Atkinson, Mark A.
    DIABETOLOGIA, 2016, 59 (04) : 870 - 872
  • [2] Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]
    Begovatz, Paul
    Bierwagen, Alessandra
    Lundbom, Jesper
    Roden, Michael
    DIABETOLOGIA, 2015, 58 (11) : 2679 - 2681
  • [3] Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]
    Paul Begovatz
    Alessandra Bierwagen
    Jesper Lundbom
    Michael Roden
    Diabetologia, 2015, 58 : 2679 - 2681
  • [4] Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, SzymaA"ska-Garbacz E, Pawowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter]
    Yudkin, J. S.
    Richter, B.
    Gale, E. A. M.
    DIABETOLOGIA, 2011, 54 (03) : 707 - 708
  • [5] Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, Szymańska-Garbacz E, Pawłowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter]
    J. S. Yudkin
    B. Richter
    E. A. M. Gale
    Diabetologia, 2011, 54 : 707 - 708
  • [6] Increasing evidence of the benefits of a transition coordinator in type 1 diabetes. Reply to White M, O’Connell M, Steinbeck K et al. [letter]
    Danièle Pacaud
    Sonia Butalia
    Diabetologia, 2021, 64 : 2352 - 2353
  • [7] Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [letter]
    Eri Wada
    Takeshi Onoue
    Tamaki Kinoshita
    Ayaka Hayase
    Tomoko Handa
    Masaaki Ito
    Mariko Furukawa
    Takayuki Okuji
    Tomoko Kobayashi
    Shintaro Iwama
    Mariko Sugiyama
    Hiroshi Takagi
    Daisuke Hagiwara
    Hidetaka Suga
    Ryoichi Banno
    Motomitsu Goto
    Hiroshi Arima
    Diabetologia, 2022, 65 : 252 - 253
  • [8] Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [letter]
    Wada, Eri
    Onoue, Takeshi
    Kinoshita, Tamaki
    Hayase, Ayaka
    Handa, Tomoko
    Ito, Masaaki
    Furukawa, Mariko
    Okuji, Takayuki
    Kobayashi, Tomoko
    Iwama, Shintaro
    Sugiyama, Mariko
    Takagi, Hiroshi
    Hagiwara, Daisuke
    Suga, Hidetaka
    Banno, Ryoichi
    Goto, Motomitsu
    Arima, Hiroshi
    DIABETOLOGIA, 2022, 65 (01) : 252 - 253
  • [9] Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
    Jessica L. Dunne
    Sarah J. Richardson
    Mark A. Atkinson
    Maria E. Craig
    Knut Dahl-Jørgensen
    Malin Flodström-Tullberg
    Heikki Hyöty
    Richard E. Lloyd
    Noel G. Morgan
    Alberto Pugliese
    Diabetologia, 2019, 62 : 1100 - 1103
  • [10] Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
    Dunne, Jessica L.
    Richardson, Sarah J.
    Atkinson, Mark A.
    Craig, Maria E.
    Dahl-Jorgensen, Knut
    Flodstroem-Tullberg, Malin
    Hyoety, Heikki
    Lloyd, Richard E.
    Morgan, Noel G.
    Pugliese, Alberto
    DIABETOLOGIA, 2019, 62 (06) : 1100 - 1103
12